Navigation Links
US Reportedly Experimenting on Nepali Soldiers

The US Government is reportedly using Nepali soldiers for experiments for finding a vaccine for Hepatitis. The vaccine is expected to protect the US soldiers while serving abroad. Hepatitis E is reported to account for half the hepatitis cases in lesser developed nations. //In 1995, the US Armed Forces Research Institute of Medical Sciences (AFRIMS), the Thai-based branch of Walter Reed Army Institute of Research, set up a unit in Katmandu to conduct clinical trials.

Robert McNair-Scott of AFRIMS was the principal US investigator and Mrigendra Shrestha his counterpart in Nepal. Lt Col Robert Kuschner was the trial's project director from the Walter Reed Army Institute of Research. The vaccine, patented by Californian company Genelabs and licensed by GlaxoSmithKline, is to hit the market in 2007. In February 2000, the research unit announced a trial would be held with 8,000 volunteers from Lalitpur District adjoining Katmandu, with 3,000 of them being administered the vaccine or placebo.

However, the plan was scuttled as the then deputy mayor, Ramesh Chitrakar, and other members of the local government body objected, saying the mayor had not consulted them. They also expressed misgivings as to whether the volunteers knew what they were walking into. Chitrakar is reported to have alleged that the researchers offered him and other dissenters watches and luxury goods to go along with the plan. However, the Nepali media and NGOs also took up the issue and the ensuing furor made the researchers abandon the idea of civilian volunteers.

Undeterred, the researchers then struck a deal with the Royal Nepalese Army (RNA) that 2,000 soldiers would "volunteer" to be the human guinea pigs. Author Jason Andrews says in The American Journal of Bioethics: "Noting the millions of dollars, military training, and arms that the (US) State Department and Military have been giving to the RNA to help them put down the Maoist rebellion, it seems plaus ible that the resultant military and economic dependence of the host institution/population (RNA) upon the research sponsor (the U.S. Military) threatened the voluntary nature of the institutional and individual participation in the trial."

Though the trial ended in 2003, it is not known who the volunteer soldiers are and what their present medical condition is. Last week, Glaxo released information at a scientific meeting, saying the vaccine was successful, but kept silent about making it available in Nepal. Now epidemiologists at Yale's School of Medicine and other activists have raised the issue afresh, expressing the fear that the trial might have been unethical.

"The poorest of the poor were used as subjects," a Yale project staff said on condition of anonymity. "There's no plan for getting the vaccine to the (Nepali) population, despite clearly pitching the trial as an attempt to address this disease for Nepalis. It appears that the vaccine will be developed as a traveler’s vaccine at best."

The fear seems plausible since in the 1980s, the same Walter Reed Army Institute of Research sponsored the development of a typhoid vaccine in Nepal. However, though typhoid is endemic in Nepal, one of the poorest countries in the world, the vaccine is not widely used.

Edited IANS
'"/>




Related medicine news :

1. Indonesia Reportedly Fires Top Animal Health Official
2. Nepali Rhesus May be Used as an Alternate for HIV/AIDS Research
3. Nepali Doctor Conferred Asian of the Year Award
4. Move to make HIV Tests mandatory For Soldiers In Northeast
5. Book Seeks To Rehabilitate Soldiers
6. Ill Health among Soldiers Returning From Iraq
7. Personality Disorders Caused Army To Let Go Of 1,000 Soldiers
8. Yoga to De-stress Indian Army Soldiers
9. Soldiers Returning From Iraq Suffer From Diminished Mental Functioning
10. Soldiers Exposed To Gunshot Noise Need Better Hearing Protection
11. Soldiers Readying to Fight Stress With Yoga
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... February 09, 2016 , ... METTLER TOLEDO has ... personnel have a basic understanding of the techniques they use so they can ... help them reduce waste and rework to create a leaner overall lab experience. ...
(Date:2/9/2016)... ... ... i2i Systems, an early innovator and developer of population health management technology, ... report, Population Health Management 2015: How Far Can Your Vendor Take You? , ... The latest KLAS Report, leveraging over 200 user interviews, shines a light on ...
(Date:2/8/2016)... ... 08, 2016 , ... Brenntag Specialties, Inc.(BSI) , is ... & Beverage and Dietary Supplement market segments across the western ... geographies east of the Rocky Mountains since 2012. Consistent performance in business ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... L top-load case packer for pouches, bags, and flow wrapped products at WestPack ... co-packers and specialty product manufacturers step up to semi-automatic or fully-automatic case packing ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance agency ... Venice, FL area, has initiated a fundraiser for a two year old little ... days after Christmas. To support this beautiful child who is facing life’s journey ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... ORLANDO, Florida , February 9, 2016 /PRNewswire/ ... QIA) today announced a collaboration with 10x Genomics ... sequencing (NGS), single-cell biology and bioinformatics. --> ... announced a collaboration with 10x Genomics to develop ... single-cell biology and bioinformatics. --> QIAGEN ...
(Date:2/9/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a ... and heart failure, today announced that it intends to offer ... in an underwritten public offering.  The offering is subject to ... as to whether or when the offering may be completed, ... offering.   --> --> ...
Breaking Medicine Technology: